Guardion Health Sciences, Inc. Overview
Pro stress-test →Guardion Health Sciences is a clinical nutrition company that develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. As of June 2026, the company is in liquidation following its strategic exit from the consumer supplement business.
Strategic Profile
Pro stress-test →The company previously focused on ocular health products including GlaucoCetin and Lumega-Z, but shifted to a liquidation model after selling its Viactiv® brand for $17.2 million gross cash consideration in 2024. The company completed its Nasdaq delisting in October 2024 and now trades OTC as it executes its dissolution plan.
Competitive Landscape
Pro stress-test →Prior to liquidation, Guardion competed in the clinical nutrition and ocular health supplement markets against brands like Lutein supplements and nutritional products from larger nutraceutical companies. With the Viactiv divestiture, competitive positioning is no longer relevant as the company pursues orderly liquidation.
Industry Context
Guardion Health Sciences, Inc. operates in Clinical nutrition and dietary supplements (historical).
Key facts
Founded: 2009 · Headquarters: Houston, US · Employees: Unknown · Revenue: $0.07M (Q2 2024 ocular products only) · Market cap: N/A